Leader in organ transplant technologies secures institutional growth capital to drive organ preservation innovation and commercial expansion CAMBRIDGE, Mass. (BUSINESS WIRE) Paragonix Technologies, Inc., a leading organ transplant company, today announced that it has secured $24 million in Series B funding, led by.
Signet Healthcare Partners has completed a growth capital investment in LAXAI, according to a news release. LAXAI, with U.S. offices in Massachusetts and California, is.
/PRNewswire/ Leading diagnostic and therapeutic medical technology company, Laborie Medical Technologies Corp. (Laborie), announced that it has completed.
Laborie Medical Technologies Corp, in partnership with Signet Healthcare Partners, has acquired GI Supply, a Mechanicsburg, Pennsylvania-based provider of specialty endoscopy and paracentesis products.